{
  "Variants Include": [
    {
      "Gene": "PRKN",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.124G>C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "C",
            "position": "124"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "42"
          },
          "Description in input context": "R42P"
        },
        {
          "HGVS": "NM_001126112.3:c.143A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "143"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "A",
            "position": "48"
          },
          "Description in input context": "K48A"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal Recessive Juvenile Parkinsonism (ARJP)",
    "MONDO": "MONDO:0007357"
  },
  "Experiment Method": [
    {
      "Assay Method": "Circular Dichroism Spectropolarimetry",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Parkin Ubld",
        "Description": "The parkin Ubld and ubiquitin were expressed and purified from E. coli."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.124G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete unfolding",
          "Result Description": "The R42P mutation causes the complete unfolding of the parkin Ubld."
        },
        {
          "Variant": "NM_001126112.3:c.143A>T",
          "Conclusion": "Normal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The K48A mutation had little effect on the stability of the parkin Ubld or ubiquitin."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The experiments were conducted on multiple batches of recombinant proteins."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was measured multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type parkin Ubld was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Unfolded parkin Ubld was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Nonlinear global analysis of multiple data sets."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ellipticity at 222 nm with a defined minimum.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Loss of defined minimum at 222 nm and appearance of a broad featureless minimum near 230 nm.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "NMR Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "GB1-UbldR42P",
        "Description": "The GB1-UbldR42P fusion protein was expressed and purified from E. coli."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.124G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete unfolding",
          "Result Description": "The 1H-15N HSQC spectrum of GB1-UbldR42P showed a mass of peaks located in the central region of the spectrum, indicating that the UbldR42P was unfolded."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The experiments were conducted on multiple batches of recombinant proteins."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was measured multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type GB1-Ubld was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Unfolded GB1-Ubld was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Comparison of peak positions and intensities in the 1H-15N HSQC spectra."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Well-dispersed peaks with line widths appropriate for proteins in the 8-15 kDa range.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Mass of peaks located in the central region of the spectrum.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}